|
Index of reports
> Cases with Diarrhoea (121)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Sandostatin (Octreotide) where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 121 Next >>
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Flushing, Fatigue, Diarrhoea, Pain in Extremity, Pain, Dizziness, Muscle Spasms
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Sandostatin
Dosage: every 12 hrs
Start date: 2012-08-14
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2012-07-04
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2012-07-04
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Tremor, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Feeling Jittery, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: male
Reactions: Abdominal Pain, Productive Cough, Pruritus, Nasopharyngitis, Metastases To Liver, Pyrexia, Faecal Volume Increased, Hot Flush, Fatigue, Cough, Decreased Appetite, Abdominal Pain Lower, Vomiting, Pain in Extremity, Nausea, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Arthralgia, Gastrointestinal Neoplasm, Diarrhoea, Dysphonia, Neoplasm Malignant, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Antibiotics; Morphine
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: female
Reactions: Abdominal Pain, Fatigue, Diarrhoea, Arthralgia, Pain in Extremity, Insomnia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, bid
Indication: Acromegaly
Start date: 2009-07-07
Sandostatin LAR
Dosage: 20 mg, monthly
Indication: Acromegaly
Start date: 2009-07-24
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, monthly
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-27
Patient: female
Reactions: Productive Cough, Contusion, Bone Pain, Chills, Flatulence, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Malaise, Road Traffic Accident, Depression, Cough, Ligament Sprain, Defaecation Urgency, Blood Pressure Systolic Increased, Pain in Extremity, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Carcinoid Tumour
Start date: 2009-05-21
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Indication: Carcinoid Tumour
Start date: 2009-06-01
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: male
Reactions: Intestinal Ischaemia, Blood Iron Decreased, Abdominal Pain, Thrombosis, Lymphadenopathy, Intestinal Obstruction, Gastrointestinal Stenosis, Blood Magnesium Decreased, Transferrin Saturation Decreased, Gastrointestinal Ulcer, Diarrhoea, Colonic Stenosis, Gastrointestinal Disorder, Hypoalbuminaemia, Abdominal Distension, Impaired Gastric Emptying, Small Intestinal Stenosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Arixtra
Start date: 2012-01-01
Arixtra
Dosage: 2.5 mg, daily
Start date: 2012-03-06
End date: 2012-03-01
Atarax
Codeine Syrup
Esomeprazole Sodium
Dosage: 40 mg, daily
Start date: 2012-03-06
Imodium
Dosage: 2 df, tid
End date: 2012-03-01
Imodium
Dosage: 3 df, qid
Start date: 2012-03-06
Quetiapine
Dosage: 600 mg, 1h before the dinner
Start date: 2012-02-06
Quetiapine
Dosage: 600 mg, in the evening
Start date: 2012-03-06
Sandostatin
Start date: 2012-02-01
End date: 2012-03-01
Sandostatin
Dosage: 100 mcg , bid
Start date: 2012-03-06
End date: 2012-03-01
Tranxene
Dosage: 5 mg, in the evening
Start date: 2012-03-06
Tranxene
Dosage: 50 mg, tid
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Spasfon; Chlorpromazine HCL; Acetaminophen; Haloperidol Lactate; Augmentin '500'
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-23
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Cough, Nervousness, Injection Site Mass, Back Pain, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Depressed Mood, Frustration, DRY Eye, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-22
Patient: male
Reactions: Abdominal Pain, Nausea, Blood Pressure Systolic Increased, Flatulence, Gastrointestinal Inflammation, Biliary Colic, Diarrhoea, Dizziness
Drug(s) suspected as cause:
Sandostatin
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Colitis Microscopic
Start date: 2010-10-18
Other drugs received by patient: Budesonide; Lomotil
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-17
Patient: female
Reactions: Death, Abdominal Pain, Confusional State, Neoplasm Malignant, Diarrhoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Sandostatin
Start date: 2012-06-01
Sandostatin LAR
Dosage: 30 mg, monthly
Indication: Neuroendocrine Tumour
Start date: 2012-06-29
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-08-16
Patient: male
Reactions: Dyspnoea, Disorientation, Discomfort, Blood Glucose Decreased, Abdominal Discomfort, Flushing, Diarrhoea, Blood Glucose Fluctuation, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Sandostatin LAR
Dosage: 20 mg, (every 2 weeks)
Other drugs received by patient: Lantus; Novorapid
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-14
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Blood Pressure Systolic Increased, Suffocation Feeling, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Cough, Blood Pressure Diastolic Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2011-07-15
Other drugs received by patient: Dicyclomine; Bisoprolol; Metoprolol
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-08-10
Patient: female
Reactions: Diarrhoea, Nausea, Hypotension, Headache
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Blinded Som230
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin LAR
Dosage: 40 mg, qmo (every 4 weeks)
Indication: Metastatic Carcinoid Tumour
Start date: 2009-07-06
End date: 2011-12-13
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-07
Patient: female
Reactions: Large Intestine Perforation, Drug Ineffective, Urinary Tract Infection, Iatrogenic Injury, Intestinal Obstruction, Foot Fracture, Postoperative Wound Infection, Diarrhoea, Dehydration, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, bid
Indication: Crohn's Disease
Start date: 2010-01-01
Sandostatin
Dosage: 100 ug, bid
Start date: 2010-02-01
Sandostatin LAR
Dosage: 30 mg, once a month
Indication: Crohn's Disease
Start date: 2010-07-29
End date: 2010-08-31
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Start date: 2010-10-18
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 20 mg, tiw
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-06
Patient: female
Reactions: Nausea, Diarrhoea, Hypotension, Headache
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Blinded Som230
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin
Dosage: double blind
Indication: Metastatic Carcinoid Tumour
Start date: 2011-06-01
End date: 2011-12-01
Sandostatin LAR
Dosage: 40 mg, qmo (every 4 weeks)
Indication: Metastatic Carcinoid Tumour
Start date: 2009-07-06
End date: 2011-12-13
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-08-03
Patient: male
Reactions: Abdominal Pain, Nasopharyngitis, Pruritus, Metastases To Liver, Faecal Volume Increased, Fatigue, Hot Flush, Decreased Appetite, Abdominal Pain Lower, Vomiting, Nausea, Pain in Extremity, Abnormal Faeces, Injection Site Pain, Skin Plaque, Flushing, Abdominal Mass, Diarrhoea, Gastrointestinal Neoplasm, Neoplasm Malignant, Dysphonia, Arthralgia, Visual Impairment, Vision Blurred, Lacrimation Increased, Depressed Mood
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Start date: 2010-03-01
Sandostatin
Indication: Neuroendocrine Tumour
End date: 2008-01-01
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-03-13
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Other drugs received by patient: Morphine Sulfate
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-08-01
Patient: female
Reactions: Haemorrhage, Rectal Haemorrhage, Malaise, Fatigue, White Blood Cell Count Increased, Lethargy, Vomiting, Loss of Control of Legs, Nausea, Urinary Tract Infection, Injection Site Pain, Facial Pain, Blood Creatine Increased, Tremor, Discomfort, Haemoglobin Decreased, Diarrhoea, Liver Abscess, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Indication: Carcinoid Tumour
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Start date: 2011-07-05
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Carcinoid Tumour
Start date: 2011-07-05
Other drugs received by patient: Norfloxacin
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-07-31
Patient: male
Reactions: Flushing, Abdominal Discomfort, Dyspnoea, Diarrhoea, Blood Glucose Fluctuation, Disorientation, Feeling Abnormal, Discomfort
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Carcinoid Syndrome
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Syndrome
Start date: 2011-10-12
Other drugs received by patient: Novorapid; Lantus
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-25
Patient: female
Reactions: Productive Cough, Contusion, Flatulence, Chills, Bone Pain, Hepatic Lesion, Neoplasm Progression, Constipation, Fall, Faeces Discoloured, Road Traffic Accident, Malaise, Depression, Ligament Sprain, Cough, Defaecation Urgency, Pain in Extremity, Blood Pressure Systolic Increased, Breast Neoplasm, Diarrhoea, Alopecia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Carcinoid Tumour
Start date: 2009-05-21
Sandostatin LAR
Dosage: 30 mg every 4 weeks
Indication: Carcinoid Tumour
Start date: 2009-06-01
Possible Sandostatin side effects in female
Reported by a physician from Canada on 2012-07-25
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Confusional State, Weight Decreased, Incorrect Route of Drug Administration, Drug Ineffective, Blood Thyroid Stimulating Hormone Increased, Incorrect Storage of Drug, Weight Increased, Injection Site Discomfort, Injection Site Erythema, Malaise, Fatigue, Hot Flush, Oedema Peripheral, Dizziness, Abdominal Distension, Mood Swings, Muscle Spasms, Injection Site Mass, Pain in Extremity, Blood Pressure Systolic Increased, Injection Site Pain, Thyroxine Increased, Flushing, Diarrhoea, Visual Impairment, Vertigo, Feeling Abnormal
Drug(s) suspected as cause:
Sandostatin
Dosage: 0.75 ml, bid
Sandostatin
Dosage: 7 ug, qd
Indication: Carcinoid Syndrome
Start date: 2008-11-06
Sandostatin
Dosage: 150 ug, tid (prn)
Start date: 2011-09-20
Sandostatin
Dosage: 0.75 ml, tid prn
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, every four weeks
Indication: Carcinoid Syndrome
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2007-03-20
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Start date: 2012-05-04
Possible Sandostatin side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-23
Patient: male
Reactions: Inappropriate Schedule of Drug Administration, Abdominal Pain, Blood Pressure Systolic Increased, Flatulence, Hyperhidrosis, Abdominal Pain Upper, Diarrhoea, Feeling of Body Temperature Change, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Start date: 2010-08-02
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2009-08-24
Sandostatin LAR
Dosage: 10 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2010-09-07
Possible Sandostatin side effects in male
Reported by a physician from Canada on 2012-07-18
Patient: male
Reactions: Abdominal Pain, Dyspnoea, Suffocation Feeling, Blood Pressure Systolic Increased, Wheezing, Rhinorrhoea, Injection Site Pain, Diarrhoea, Crepitations, Bronchitis, Bradycardia, Asthenia, Blood Pressure Diastolic Decreased, Cough, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, tid
End date: 2011-07-05
Sandostatin
Dosage: 50 ug, tid
Indication: Carcinoid Tumour
Start date: 2011-06-23
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Indication: Carcinoid Tumour
Start date: 2011-07-14
Other drugs received by patient: Bisoprolol Fumarate; Metoprolol Succinate; Dicyclomine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Contusion, Blood Pressure Systolic Increased, Metastases To Liver, Diarrhoea, Gastrointestinal Carcinoma, Fall, RIB Fracture
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, once/single
Indication: Carcinoid Tumour
Start date: 2010-09-30
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Carcinoid Tumour
Start date: 2010-10-28
End date: 2011-08-11
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-17
Patient: female
Reactions: Abdominal Pain, Flatulence, Pain, Constipation, Fall, Abdominal Pain Upper, Herpes Zoster, Fatigue, Malaise, Dizziness, Abdominal Distension, Anuria, Blood Pressure Increased, Back Pain, Humerus Fracture, Gastrointestinal Motility Disorder, Vomiting, Pain in Extremity, Nausea, Flushing, Arthralgia, Diarrhoea, Ocular Hyperaemia, Flank Pain, Vision Blurred, Asthenia, Neuralgia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, tid
Indication: Small Intestine Carcinoma
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, qmo
Sandostatin LAR
Dosage: 30 mg, tiw
Indication: Small Intestine Carcinoma
Start date: 2009-05-26
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Other drugs received by patient: Xeloda; Capecitabine
Possible Sandostatin side effects in female
Reported by a consumer/non-health professional from Canada on 2012-07-11
Patient: female, weighing 49.4 kg (108.8 pounds)
Reactions: Weight Decreased, Rectal Haemorrhage, Pain, Oral Discomfort, Injection Site Erythema, Lymph Node Pain, Anorectal Discomfort, Abdominal Distension, Dizziness, Nervousness, Cough, Injection Site Mass, Nausea, Haemorrhoids, Injection Site Pain, Hypoaesthesia, Diarrhoea, Alopecia, Pollakiuria, Blood Pressure Decreased, Frustration, DRY Eye, Depressed Mood, Asthenia
Drug(s) suspected as cause:
Sandostatin
Dosage: 50 ug, unk
Indication: Thyroid Cancer
Sandostatin
Dosage: 100 ug, bid
End date: 2012-02-23
Sandostatin LAR
Dosage: 30 mg every 3 weeks
End date: 2007-03-06
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Thyroid Cancer
Start date: 2004-07-13
End date: 2007-03-06
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-04
Patient: female
Reactions: Pneumonia, Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Diarrhoea, Condition Aggravated
Adverse event resulted in: death
Drug(s) suspected as cause:
Sandostatin
Dosage: 30 mg, unk
Indication: Hepatic Cirrhosis
Sandostatin
Indication: Varices Oesophageal
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-02
Patient: female
Reactions: Drug Effect Decreased, Urinary Tract Infection, Hypotension, Intestinal Obstruction, Body Temperature Decreased, Wound Infection, Foot Fracture, Diarrhoea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 100 ug, bid
Indication: Crohn's Disease
Start date: 2010-01-01
Sandostatin
Dosage: 100 ug, bid
Start date: 2010-02-01
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Crohn's Disease
Start date: 2010-07-29
End date: 2010-08-31
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 30 mg, tiw
Sandostatin LAR
Dosage: 20 mg, tiw
Sandostatin LAR
Dosage: 40 mg, every 4 weeks
Start date: 2010-10-18
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-27
Patient: female
Reactions: Steatorrhoea, Cellulitis, Pain in Extremity, Sciatica, Abnormal Faeces, Erythema, Abdominal Pain Upper, Pancreatic Disorder, Diarrhoea, Oedema Peripheral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Sandostatin
Dosage: 150 mg, unk
Sandostatin LAR
Dosage: 20 mg, every 4 weeks
Indication: Neuroendocrine Tumour
Start date: 2010-10-30
Possible Sandostatin side effects in female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-26
Patient: female
Reactions: Blood Pressure Systolic Increased, Fall, Suicidal Ideation, Abdominal Discomfort, Fatigue, Malaise, Diarrhoea, Psychiatric Symptom, Mental Disorder, Vasculitis, Depressed Mood
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: unk ukn, unk
Indication: Neuroendocrine Tumour
Start date: 2011-07-11
Sandostatin LAR
Dosage: 20 mg, qmo
Indication: Neuroendocrine Tumour
Start date: 2011-07-26
Possible Sandostatin side effects in male
Reported by a consumer/non-health professional from Canada on 2012-06-22
Patient: male
Reactions: Abdominal Pain, Headache, Erythema, Oedema Peripheral, Blood Pressure Abnormal, Nervousness, Blood Pressure Systolic Decreased, Chest Discomfort, Cardiac Murmur, Blood Urine Present, Pain in Extremity, Hypoaesthesia, Tremor, Carcinoid Tumour of THE Pancreas, Flushing, Heart Rate Decreased, Vision Blurred, Fall, Abdominal Pain Upper, Hepatomegaly, Chest Pain, Dizziness, Heart Rate Irregular, Dyspnoea, Vomiting, Nausea, Retching, Lung Neoplasm, Burning Sensation, Diarrhoea, Heart Rate Increased, Visual Impairment, Hypertension, Blood Pressure Fluctuation, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sandostatin
Dosage: 5 ug, tid
Indication: Carcinoid Tumour of THE Small Bowel
Start date: 2010-04-22
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Sandostatin LAR
Dosage: 30 mg, every 3 weeks
Start date: 2010-08-25
Sandostatin LAR
Dosage: 30 mg, qmo
Indication: Small Intestine Carcinoma
Start date: 2010-08-22
Sandostatin LAR
Dosage: 30 mg, every 4 weeks
Other drugs received by patient: Propranolol; Lyrica; Codeine; Lantus; Rasilez D; Ranitidine
Page 1 Next >>
|
